These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
176 related articles for article (PubMed ID: 32760820)
21. Clinical considerations for medication-related osteonecrosis of the jaw: a comprehensive literature review. Kawahara M; Kuroshima S; Sawase T Int J Implant Dent; 2021 May; 7(1):47. PubMed ID: 33987769 [TBL] [Abstract][Full Text] [Related]
22. The effect of drug holiday on preventing medication-related osteonecrosis of the jaw in osteoporotic rat model. Zhu WY; Yang WF; Wang L; Lan X; Tao ZY; Guo J; Xu J; Qin L; Su YX J Orthop Translat; 2023 Mar; 39():55-62. PubMed ID: 36721766 [TBL] [Abstract][Full Text] [Related]
23. Medical students' knowledge of medication related osteonecrosis of the jaw. Franchi S; Brucoli M; Boffano P; Dosio C; Benech A J Stomatol Oral Maxillofac Surg; 2020 Sep; 121(4):344-346. PubMed ID: 31672685 [TBL] [Abstract][Full Text] [Related]
24. Awareness among patient at risk of developing Medication Related Osteonecrosis of the Jaw (MRONJ) - A primary prevention strategy. Al Abdullateef A; Alhareky MS Saudi Pharm J; 2020 Jun; 28(6):771-778. PubMed ID: 32550810 [TBL] [Abstract][Full Text] [Related]
25. Awareness of Medication-Related Osteonecrosis of the Jaws Amongst Patients on Antiresorptive and Antiangiogenic Medications. Assari AS; Alanazi Y; Mubarak Algharbi E; Abuhabsha A; Alshammry B; Alzahrani A; Alduhaim A; Abuhaimed R Cureus; 2024 Jan; 16(1):e52896. PubMed ID: 38406100 [TBL] [Abstract][Full Text] [Related]
26. Awareness of medication related osteonecrosis of the jaws (MRONJ) amongst general dental practitioners. Tanna N; Steel C; Stagnell S; Bailey E Br Dent J; 2017 Jan; 222(2):121-125. PubMed ID: 28126996 [TBL] [Abstract][Full Text] [Related]
27. Medication-related osteonecrosis of the jaw: risk factors in patients under biphosphonate versus patients under antiresorptive-antiangiogenic drugs. Ghidini G; Manfredi M; Giovannacci I; Mergoni G; Sarraj A; Mureddu M; Giunta G; Bonanini M; Meleti M; Vescovi P Minerva Stomatol; 2017 Aug; 66(4):135-140. PubMed ID: 28497661 [TBL] [Abstract][Full Text] [Related]
28. Medication-Related Osteonecrosis of the Jaw (MRONJ): A Review of Pathophysiology, Risk Factors, Preventive Measures and Treatment Strategies. AlRowis R; Aldawood A; AlOtaibi M; Alnasser E; AlSaif I; Aljaber A; Natto Z Saudi Dent J; 2022 Mar; 34(3):202-210. PubMed ID: 35935720 [TBL] [Abstract][Full Text] [Related]
29. Dental implants as risk factors for patients with medication-related osteonecrosis of the jaws (MRONJ). Pichardo SEC; van der Hee JG; Fiocco M; Appelman-Dijkstra NM; van Merkesteyn JPR Br J Oral Maxillofac Surg; 2020 Sep; 58(7):771-776. PubMed ID: 32631756 [TBL] [Abstract][Full Text] [Related]
30. Medication-related osteonecrosis of the jaw: An update on the memorial sloan kettering cancer center experience and the role of premedication dental evaluation in prevention. Owosho AA; Liang STY; Sax AZ; Wu K; Yom SK; Huryn JM; Estilo CL Oral Surg Oral Med Oral Pathol Oral Radiol; 2018 May; 125(5):440-445. PubMed ID: 29580668 [TBL] [Abstract][Full Text] [Related]
31. Knowledge, attitudes and practices of physicians and dentists on medication-related osteonecrosis of the jaw: a cross-sectional survey. Kazmi SMR; Siddiqui HK; Khan FR; Khan SRA Br Dent J; 2023 May; ():. PubMed ID: 37225843 [TBL] [Abstract][Full Text] [Related]
32. Awareness, perceptions and attitudes toward medication-related osteonecrosis of the jaw among physicians who treat osteoporosis. Aljohani S Saudi Pharm J; 2023 Sep; 31(9):101707. PubMed ID: 37546526 [TBL] [Abstract][Full Text] [Related]
33. CT imaging features of antiresorptive agent-related osteonecrosis of the jaw/medication-related osteonecrosis of the jaw. Baba A; Goto TK; Ojiri H; Takagiwa M; Hiraga C; Okamura M; Hasegawa S; Okuyama Y; Ogino N; Yamauchi H; Kobashi Y; Yamazoe S; Munetomo Y; Mogami T; Nomura T Dentomaxillofac Radiol; 2018 May; 47(4):20170323. PubMed ID: 29365278 [TBL] [Abstract][Full Text] [Related]
34. Is the prevalence of the medication-related osteonecrosis of the jaws underestimated, evaluation in oncological and non-oncological disease. Galis B; Zajko J; Hirjak D; Vanko L; Kupcova I; Jurkemik J; Gengelova P; Mikuskova K; Halmova K; Riznic M; Czako L Bratisl Lek Listy; 2017; 118(12):724-731. PubMed ID: 29322803 [TBL] [Abstract][Full Text] [Related]
35. Physicians' awareness of bisphosphonates-related osteonecrosis of the jaw. Al-Mohaya MA; Al-Khashan HI; Mishriky AM; Al-Otaibi LM Saudi Med J; 2011 Aug; 32(8):830-5. PubMed ID: 21858393 [TBL] [Abstract][Full Text] [Related]
36. Several issues regarding the diagnostic imaging of medication-related osteonecrosis of the jaw. Kim JE; Yoo S; Choi SC Imaging Sci Dent; 2020 Dec; 50(4):273-279. PubMed ID: 33409135 [TBL] [Abstract][Full Text] [Related]
37. Knowledge and attitudes of French dentists on bone resorption inhibitors (bisphosphonates and denosumab): A cross-sectional study. Arnaud MP; Talibi S; Lejeune-Cairon S J Stomatol Oral Maxillofac Surg; 2022 Apr; 123(2):163-170. PubMed ID: 33930600 [TBL] [Abstract][Full Text] [Related]
38. Dental Implant Placement in Patients With a History of Medications Related to Osteonecrosis of the Jaws: A Systematic Review. Sher J; Kirkham-Ali K; Luo JD; Miller C; Sharma D J Oral Implantol; 2021 Jun; 47(3):249-268. PubMed ID: 32699903 [TBL] [Abstract][Full Text] [Related]
39. Medication-related osteonecrosis of the jaw: Case series and literature review. Kimathi D; Butt F; Guthua S; Waweru W Clin Case Rep; 2024 Apr; 12(4):e8788. PubMed ID: 38645603 [TBL] [Abstract][Full Text] [Related]
40. Medication-related osteonecrosis of the jaw: Clinical and practical guidelines. Rosella D; Papi P; Giardino R; Cicalini E; Piccoli L; Pompa G J Int Soc Prev Community Dent; 2016; 6(2):97-104. PubMed ID: 27114946 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]